Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials - Frere, C; Farge, D; Schrag, D; Prata, P H; Connors, J M (J Hematol Oncol, 2022)